Title: Li D, et al. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene. 2008 Aug 7;27(34):4702-11.
289499-45-2
850140-73-7
1110813-31-4
267243-28-7
1042385-75-0
1637254-93-3
1211537-03-9 | 5-Bromo-3-cyclopropyl-1h-pyrazolo[3,4-b]pyridine | AA009XHZ | MFCD18260550
1401863-51-1 | 9-Benzyl-2-bromo-9h-carbazole | AA009Y60 | MFCD30469064
1333392-80-5 | 5-fluoro-2-(isopropoxyMethyl)phenylboronic acid | AA009YGB | MFCD14687289
1353859-00-3 | CX-6258 Hydrochloride | AA009YW9 | MFCD26142938
1351580-15-8 | (R)-1-(2,3-Difluorophenyl)ethanamine hydrochloride | AA009ZCI | MFCD12757703
1428532-86-8 | (5-Fluoro-3-methylpyridin-2-yl)methanamine hydrochloride | AA009ZYL | MFCD23701122
1213206-88-2 | (2S)-2-amino-3-(4-bromo-2-fluorophenyl)propanoic acid | AA00A0DR | MFCD14561453
1269393-89-6 | 1H-Benzimidazole-2-ethanamine, 6-methoxy-N-methyl-, hydrochloride (1 | AA00A0S6 | MFCD18483388
1246094-80-3 | Cyclopropyl-methyl-(1,2,3,4-tetrahydro-naphthalen-2-yl)-amine hydrobromide | AA00A1CU | MFCD14525465
1220036-52-1 | 2-Amino-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one hydrochloride | AA00A2G8 | MFCD13561989